ELEVATE Trademark Information

Trademark by Alnylam Pharmaceuticals, Inc.

Maintaining a clinical registry database for patients with genetic mutations that cause enzyme defects and acute hepatic porphyria; maintaining a registry on the clinical outcomes of acute hepatic porphyria in patients over time

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (035)
Advertising; business management; business administration; office functions.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: ELEVATE
Status/Status Date:
NOTICE OF ALLOWANCE - ISSUED
3/22/2022
Serial Number: 90667344
Filing Date: 4/23/2021
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Maintaining a clinical registry database for patients with genetic mutations that cause enzyme defects and acute hepatic porphyria; maintaining a registry on the clinical outcomes of acute hepatic porphyria in patients over time
Mark Description: NOT AVAILABLE
Type Of Mark: Service Mark
Published For Opposition Date: 1/25/2022
Last Applicant/Owner:
Alnylam Pharmaceuticals, Inc.
********
********
***** ****
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
********
********
***** ****
Current Status:
NOTICE OF ALLOWANCE - ISSUED
3/22/2022
Correspondent Search:
ANN LAMPORT HAMMITTE is a correspondent of ELEVATE trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on